Global Short Bowel Syndrome (SBS) Drugs Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
- GLO2771955
- 0 Pages
- September 2018
- Medical Devices
Scope of the Report:
This report studies the Short Bowel Syndrome (SBS) Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Short Bowel Syndrome (SBS) Drugs market by product type and applications/end industries.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
The global Short Bowel Syndrome (SBS) Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Short Bowel Syndrome (SBS) Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Merck
Shire
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
Market Segment by Applications, can be divided into
Hospitals
Clinics
Retail Pharmacies
1 Short Bowel Syndrome (SBS) Drugs Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome (SBS) Drugs
1.2 Classification of Short Bowel Syndrome (SBS) Drugs by Types
1.2.1 Global Short Bowel Syndrome (SBS) Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Types in 2017
1.2.3 Glucagon-Like Peptide-2 (GLP-2)
1.2.4 Growth Hormone
1.2.5 Glutamine
1.2.6 Other
1.3 Global Short Bowel Syndrome (SBS) Drugs Market by Application
1.3.1 Global Short Bowel Syndrome (SBS) Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Global Short Bowel Syndrome (SBS) Drugs Market by Regions
1.4.1 Global Short Bowel Syndrome (SBS) Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Short Bowel Syndrome (SBS) Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Short Bowel Syndrome (SBS) Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Short Bowel Syndrome (SBS) Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Short Bowel Syndrome (SBS) Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Short Bowel Syndrome (SBS) Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Short Bowel Syndrome (SBS) Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Business Overview
2.1.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Shire
2.2.1 Business Overview
2.2.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Emmaus Medical
2.3.1 Business Overview
2.3.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ardelyx
2.4.1 Business Overview
2.4.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ardelyx Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Naia Pharmaceuticals
2.5.1 Business Overview
2.5.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Nutrinia
2.6.1 Business Overview
2.6.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Nutrinia Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 OxThera
2.7.1 Business Overview
2.7.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 OxThera Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sancilio Pharmaceuticals
2.8.1 Business Overview
2.8.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Zealand Pharma
2.9.1 Business Overview
2.9.2 Short Bowel Syndrome (SBS) Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Short Bowel Syndrome (SBS) Drugs Market Competition, by Players
3.1 Global Short Bowel Syndrome (SBS) Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Short Bowel Syndrome (SBS) Drugs Players Market Share
3.2.2 Top 10 Short Bowel Syndrome (SBS) Drugs Players Market Share
3.3 Market Competition Trend
4 Global Short Bowel Syndrome (SBS) Drugs Market Size by Regions
4.1 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Regions
4.2 North America Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
5 North America Short Bowel Syndrome (SBS) Drugs Revenue by Countries
5.1 North America Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
5.2 USA Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
6 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Countries
6.1 Europe Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
6.2 Germany Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
6.4 France Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Countries
7.1 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
7.2 China Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
7.5 India Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
8 South America Short Bowel Syndrome (SBS) Drugs Revenue by Countries
8.1 South America Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
8.2 Brazil Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Short Bowel Syndrome (SBS) Drugs by Countries
9.1 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
10 Global Short Bowel Syndrome (SBS) Drugs Market Segment by Type
10.1 Global Short Bowel Syndrome (SBS) Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Short Bowel Syndrome (SBS) Drugs Market Forecast by Type (2018-2023)
10.3 Glucagon-Like Peptide-2 (GLP-2) Revenue Growth Rate (2013-2023)
10.4 Growth Hormone Revenue Growth Rate (2013-2023)
10.5 Glutamine Revenue Growth Rate (2013-2023)
10.6 Other Revenue Growth Rate (2013-2023)
11 Global Short Bowel Syndrome (SBS) Drugs Market Segment by Application
11.1 Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Application (2013-2018)
11.2 Short Bowel Syndrome (SBS) Drugs Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Retail Pharmacies Revenue Growth (2013-2018)
12 Global Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2018-2023)
12.1 Global Short Bowel Syndrome (SBS) Drugs Market Size Forecast (2018-2023)
12.2 Global Short Bowel Syndrome (SBS) Drugs Market Forecast by Regions (2018-2023)
12.3 North America Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
12.6 South America Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Short Bowel Syndrome (SBS) Drugs Picture
Table Product Specifications of Short Bowel Syndrome (SBS) Drugs
Table Global Short Bowel Syndrome (SBS) Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Types in 2017
Figure Glucagon-Like Peptide-2 (GLP-2) Picture
Figure Growth Hormone Picture
Figure Glutamine Picture
Figure Other Picture
Table Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Application (2013-2023)
Figure Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Retail Pharmacies Picture
Table Global Market Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Merck Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Shire Basic Information, Manufacturing Base and Competitors
Table Shire Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Shire Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Emmaus Medical Basic Information, Manufacturing Base and Competitors
Table Emmaus Medical Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Emmaus Medical Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Ardelyx Basic Information, Manufacturing Base and Competitors
Table Ardelyx Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Ardelyx Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Naia Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Naia Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Nutrinia Basic Information, Manufacturing Base and Competitors
Table Nutrinia Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Nutrinia Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table OxThera Basic Information, Manufacturing Base and Competitors
Table OxThera Short Bowel Syndrome (SBS) Drugs Type and Applications
Table OxThera Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Sancilio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Zealand Pharma Basic Information, Manufacturing Base and Competitors
Table Zealand Pharma Short Bowel Syndrome (SBS) Drugs Type and Applications
Table Zealand Pharma Short Bowel Syndrome (SBS) Drugs Revenue, Gross Margin and Market Share (2016-2017)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Players (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Players (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Players in 2016
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Players in 2017
Figure Global Top 5 Players Short Bowel Syndrome (SBS) Drugs Revenue Market Share in 2017
Figure Global Top 10 Players Short Bowel Syndrome (SBS) Drugs Revenue Market Share in 2017
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Regions (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Regions (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Regions in 2017
Figure North America Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure South America Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Table North America Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
Table North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2017
Figure USA Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Canada Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Mexico Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Table Europe Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2017
Figure Germany Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure UK Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure France Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Russia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Italy Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2017
Figure China Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Japan Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Korea Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure India Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Table South America Short Bowel Syndrome (SBS) Drugs Revenue by Countries (2013-2018)
Table South America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2017
Figure Brazil Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Argentina Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Colombia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure UAE Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Egypt Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure Nigeria Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Figure South Africa Short Bowel Syndrome (SBS) Drugs Revenue and Growth Rate (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Type in 2017
Table Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Type (2018-2023)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Type (2018-2023)
Figure Global Glucagon-Like Peptide-2 (GLP-2) Revenue Growth Rate (2013-2018)
Figure Global Growth Hormone Revenue Growth Rate (2013-2018)
Figure Global Glutamine Revenue Growth Rate (2013-2018)
Figure Global Other Revenue Growth Rate (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue by Application (2013-2018)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Application (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Share by Application in 2017
Table Global Short Bowel Syndrome (SBS) Drugs Revenue Forecast by Application (2018-2023)
Figure Global Short Bowel Syndrome (SBS) Drugs Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Short Bowel Syndrome (SBS) Drugs Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Short Bowel Syndrome (SBS) Drugs Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
Figure Europe Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
Figure South America Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Short Bowel Syndrome (SBS) Drugs Revenue Market Forecast (2018-2023)
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
